# Pulmonary Hypertension Research and Treatments

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the diagnosis, assessment, and treatment guidelines for pulmonary hypertension, with an emphasis on right heart assessment using echocardiography. It covers topics such as survival prediction, vascular remodeling, endothelial dysfunction, BMPR2 mutations, and hemodynamic classification. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10728 |
| Works | 271 |

## Topic papers all

Showing 15 of 271.

- [Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography](https://scholariq.org/papers/guidelines-for-the-echocardiographic-assessment-of-the-right-heart-in-adults-a/)
- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures](https://scholariq.org/papers/clinical-utility-of-doppler-echocardiography-and-tissue-doppler-imaging-in-the/)
- [Bosentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/bosentan-therapy-for-pulmonary-arterial-hypertension/)
- [A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension](https://scholariq.org/papers/a-comparison-of-continuous-intravenous-epoprostenol-prostacyclin-with/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary/)
- [Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension](https://scholariq.org/papers/expression-of-endothelin-1-in-the-lungs-of-patients-with-pulmonary-hypertension/)
- [Global Burden of Cardiovascular Diseases and Risks, 1990-2022](https://scholariq.org/papers/global-burden-of-cardiovascular-diseases-and-risks-1990-2022/)
- [Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension](https://scholariq.org/papers/macitentan-and-morbidity-and-mortality-in-pulmonary-arterial-hypertension/)
- [Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial](https://scholariq.org/papers/continuous-subcutaneous-infusion-of-treprostinil-a-prostacyclin-analogue-in/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/pulmonary-hypertension-in-heart-failure-with-preserved-ejection-fraction/)
- [Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/evidence-supporting-the-existence-of-a-distinct-obese-phenotype-of-heart-failure/)
- [Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2](https://scholariq.org/papers/mutations-in-the-activin-receptor-like-kinase-1-gene-in-hereditary-haemorrhagic/)

## Topic primary papers

Showing 15 of 139.

- [Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)](https://scholariq.org/papers/guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension-the-task/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-2/)
- [Bosentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/bosentan-therapy-for-pulmonary-arterial-hypertension/)
- [A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension](https://scholariq.org/papers/a-comparison-of-continuous-intravenous-epoprostenol-prostacyclin-with/)
- [2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension](https://scholariq.org/papers/2022-esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary/)
- [Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension](https://scholariq.org/papers/expression-of-endothelin-1-in-the-lungs-of-patients-with-pulmonary-hypertension/)
- [Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension](https://scholariq.org/papers/macitentan-and-morbidity-and-mortality-in-pulmonary-arterial-hypertension/)
- [Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial](https://scholariq.org/papers/continuous-subcutaneous-infusion-of-treprostinil-a-prostacyclin-analogue-in/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/pulmonary-hypertension-in-heart-failure-with-preserved-ejection-fraction/)
- [Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension](https://scholariq.org/papers/tricuspid-annular-displacement-predicts-survival-in-pulmonary-hypertension/)
- [Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease](https://scholariq.org/papers/continuous-intravenous-epoprostenol-for-pulmonary-hypertension-due-to-the/)
- [Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review](https://scholariq.org/papers/pulmonary-arterial-pressure-during-rest-and-exercise-in-healthy-subjects-a/)
- [Selexipag for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/selexipag-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Continuous wave doppler determination of right ventricular pressure: A simultaneous Doppler-catheterization study in 127 patients](https://scholariq.org/papers/continuous-wave-doppler-determination-of-right-ventricular-pressure-a/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.